The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes

2006 ◽  
Vol 553 (1-3) ◽  
pp. 215-221 ◽  
Author(s):  
Leif Hove-Madsen ◽  
Anna Llach ◽  
Cristina E. Molina ◽  
Cristina Prat-Vidal ◽  
Jordi Farré ◽  
...  
2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
V Jimenez-Sabado ◽  
T Lu ◽  
S Casabella ◽  
C Tarifa ◽  
A Herraiz-Martinez ◽  
...  

Abstract Background Atrial fibrillation (AF) has been associated with an increase in spontaneous calcium release induced electrical activity, which could potentially be reversed by carvedilol, a nonselective beta-blocker that also inhibits the cardiac ryanodine receptor (RyR2). Interestingly the enantiomer R-carvedilol inhibits the RyR2 but not beta-adrenergic receptors, allowing it to effectively prevent calcium release-induced spontaneous electrical activity without inducing bradycardia and hypotension. Purpose The purpose of this study was to determine how carvedilol treatment affects calcium release-induced transient inward currents (ITI) in human atrial myocytes from patients with AF; and to test the effects of R-carvedilol on spontaneous calcium release in order to assess its therapeutical utility. Methods Human atrial myocytes were isolated from patients undergoing cardiac surgery and subjected to patch-clamp technique (n=60) or confocal calcium imaging (n=6). Beta-2 adrenergic receptors were activated with the selective agonist fenoterol (3μM) and 1μM R-carvedilol was used to inhibit spontaneous calcium release events. Results Recordings of calcium release-induced transient inward currents (ITI) revealed that carvedilol treatment reduced the ITI frequency in patients with AF from 2.2±0.4 events/min in untreated patients to 0.59±0.35 events/min (p<0.01), which was even lower than the incidence in patients without AF (1.0±0.1 events/min; p<0.01). To assess the effects of R-carvedilol, myocytes were first simulated with fenoterol. This increased the calcium spark frequency from 23±15 to 960±336 events/s/1000μm2 in 16 cells from 6 patients (p<0.05). This was due to an increase in the spark site density (from 0.50±0.24 to 12.1±2.4 sites/1000μm2, p<0.001) rather than in the firing rate (0.068±0.14 vs. 0.035±0.012 sparks/s in control, p=0.14). Fenoterol also increased the spark duration from 50.9±5.4 to 77.3±4.1ms (p<0.001) without affecting the amplitude. Importantly, fenoterol also induced global calcium release events such as calcium waves and transients (2.8±1.1 vs. 0 events/min in control, p<0.05). When R-carvedilol was added, the effects of fenoterol were abolished, reducing the incidence of calcium sparks to 69±51 events/s/1000μm2 (p<0.05), the spark site density to 1.68±1.04 sites/1000μm2 (p<0.01), the spark duration to 63.4±4.3ms (p<0.05), and calcium waves and transients were reduced to 0.21±0.14 events/min (p<0.05). Conclusions Carvedilol treatment reduces the ITI frequency in patients with AF to levels below that observed at baseline in patients without AF. Furthermore, the non-beta-blocking R-carvedilol enantiomer abolishes spontaneous calcium release events induced by beta-2 adrenergic stimulation in human atrial myocytes, proposing a therapeutical utility for this compound in patients with AF linked to excessive spontaneous calcium release. Acknowledgement/Funding SAF2017-88019; Marato2015-20-30; SGR2017-1769; CIBERCV


Circulation ◽  
2004 ◽  
Vol 110 (11) ◽  
pp. 1358-1363 ◽  
Author(s):  
Leif Hove-Madsen ◽  
Anna Llach ◽  
Antoni Bayes-Genís ◽  
Santiago Roura ◽  
Enrique Rodriguez Font ◽  
...  

2011 ◽  
Vol 301 (5) ◽  
pp. H1996-H2005 ◽  
Author(s):  
M. A. Richards ◽  
J. D. Clarke ◽  
P. Saravanan ◽  
N. Voigt ◽  
D. Dobrev ◽  
...  

Transverse (t) tubules are surface membrane invaginations that are present in all mammalian cardiac ventricular cells. The apposition of L-type Ca2+ channels on t tubules with the sarcoplasmic reticulum (SR) constitutes a “calcium release unit” and allows close coupling of excitation to the rise in systolic Ca2+. T tubules are virtually absent in the atria of small mammals, and therefore Ca2+ release from the SR occurs initially at the periphery of the cell and then propagates into the interior. Recent work has, however, shown the occurrence of t tubules in atrial myocytes from sheep. As in the ventricle, Ca2+ release in these cells occurs simultaneously in central and peripheral regions. T tubules in both the atria and the ventricle are lost in disease, contributing to cellular dysfunction. The aim of this study was to determine if the occurrence of t tubules in the atrium is restricted to sheep or is a more general property of larger mammals including humans. In atrial tissue sections from human, horse, cow, and sheep, membranes were labeled using wheat germ agglutinin. As previously shown in sheep, extensive t-tubule networks were present in horse, cow, and human atrial myocytes. Analysis shows half the volume of the cell lies within 0.64 ± 0.03, 0.77 ± 0.03, 0.84 ± 0.03, and 1.56 ± 0.19 μm of t-tubule membrane in horse, cow, sheep, and human atrial myocytes, respectively. The presence of t tubules in the human atria may play an important role in determining the spatio-temporal properties of the systolic Ca2+ transient and how this is perturbed in disease.


2011 ◽  
Vol 589 (13) ◽  
pp. 3247-3262 ◽  
Author(s):  
Anna Llach ◽  
Cristina E. Molina ◽  
Jacqueline Fernandes ◽  
Josep Padró ◽  
Juan Cinca ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document